Reuters logo
BRIEF-La Jolla reports Q3 loss $1.19/shr
2017年10月26日 / 晚上9点23分 / 1 个月前

BRIEF-La Jolla reports Q3 loss $1.19/shr

Oct 26 (Reuters) - La Jolla Pharmaceutical Co

* La Jolla Pharmaceutical Company announces financial results for the three and nine months ended September 30, 2017 and recent corporate progress

* Q3 loss per share $1.19

* Q3 earnings per share view $-1.24 -- Thomson Reuters I/B/E/S

* La Jolla Pharmaceutical-‍as of Sept 30, 2017, co had $120.8 million in cash,cash equivalents, versus $65.7 million of cash and cash equivalents at Dec 31, 2016​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below